# Prolifagen jobs and careers

> 0 open roles at Prolifagen as of October 23, 2026. Source: https://www.thejobsmap.com/company/prolifagen

Prolifagen is harnessing the power of microRNA to prevent the progression from heart attack to heart failure. PRO302, is a patented mixture of miR302 and a hydrogel (Hyaluronic Acid) that is introduced to damaged heart tissue following a heart attack. The mixture induces a proliferation of cardiomyocytes, which can promote the regeneration of the patient’s heart muscle as well as prevent the build-up of scar tissue. This can help restore the heart’s pumping capacity and reduce the likelihood of progression to heart failure. Prolifagen internal studies on mice, pigs and in-vitro human tissue have demonstrated that administration of PRO302 induces a proliferation of cardiomyocytes and prevents post-heart attack scarring of damaged heart tissue. Prolifagen has an exclusive license with the University of Pennsylvania for three issued USPTO patents. Continuations have been filed on the existing IP.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | United States |
| Employees | 1 to 10 |
| Website | https://prolifagen.com |

## Common questions

### Is Prolifagen hiring right now?

Prolifagen has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Prolifagen's careers site.

### Where is Prolifagen headquartered?

Prolifagen is headquartered in United States.

### How do I apply for a job at Prolifagen?

Pick a role on Prolifagen's TheJobsMap page and select Apply. Every listing links to the original posting on Prolifagen's own careers site, so you apply directly with the employer.